Tag: Lyfgenia

Sickle cell disease affects over 100,000 Americans and millions worldwide, leading to chronic pain and organ damage. Recent breakthroughs in gene therapy represent a paradigm shift in care, answering the question: What is the new treatment for sickle cell disease 2025?

Sickle cell disease, a painful genetic blood disorder, affects millions worldwide, but a new era of treatment is here. Following decades of research, transformative gene therapies approved by the FDA in late 2023 represent a new treatment for sickle cell anemia, providing a potential cure for eligible patients.